UCSF School of Medicine
V

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

By UCSF School of Medicine FEATURING Vadim Koshkin
By UCSF School of Medicine FEATURING Vadim Koshkin
2 views
June 20, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Related Content

AUTOPLAY
International Urology Cancer Summit - IUCS

Second International Urology Cancer Summit

Fri, Sep 27, 2024
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

22:19
Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Feat. G. Sonpavde
17:32
Kriti Mittal

Current Updates in Urothelial Cancer: Clinical Implications for Prac…

09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
14:00
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Ca…

Feat. G. Sonpavde
22:07
Weill Cornell Medicine Oncology & Hematology

Urothelial Carcinoma: New Developments

Feat. C. Sternberg
19:30
Scripps Health

Sequencing 1L Therapies in Metastatic Urothelial Carcinoma

Feat. P. Grivas
06:01
ecancer

ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Comb…

Feat. T. Powles
10:19
University of Colorado Cancer Center

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

Feat. T. Flaig
30:03
UCSF School of Medicine

Recent Advances in Advanced Urothelial Cancers: Time for a New Stand…

Feat. T. Friedlander
11:29
Oncology Data Advisor

Enfortumab Vedotin + Pembro for Previously Untreated Advanced Urothe…

Feat. T. Powles
13:54
AdventHealth

FDA Approval of Gemcitabine-Cisplatin + Nivo as 1L Therapy for Advan…

Feat. G. Sonpavde
19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha
19:47
Janssen Oncology

All Things PSA

Feat. J. Hamilton, M. Fabrizio, M. Taha
17:03
Total Health

Emerging Trends in Localized Bladder Cancer in 2024

Feat. N. Gopal
09:12
AdventHealth

Update on the FDA Accelerated Approval of Enfortumab Vedotin + Pembr…

Feat. G. Sonpavde